NASDAQ:IMTX

Immatics - IMTX News Today

$7.15

+0.41 (+6.08%)

(As of 03/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $6.60
▼
$7.26
50-Day Range: $6.74
▼
$8.88
52-Week Range: $5.75
▼
$13.60

Volume: 784,410 shs
Average Volume: 228,705 shs
Market Capitalization: $545.04 million

P/E Ratio: 9.66
Dividend Yield: N/A
Price Target: $22.33

Institutional Ownership

Get Immatics News Delivered to You Automatically

IMTX Media Mentions By Week

IMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMTX
News Sentiment
▼
0.71

0.67
▲
Average
Medical
News Sentiment

IMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMTX Articles
This Week
▼
17

1
▲
IMTX Articles
Average Week

Source

Source	Headline
	Immatics (NASDAQ:IMTX) Receives New Coverage from Analysts at Bryan, Garnier & Co marketbeat.com - March 24 at 9:21 AM
	Immatics to Post Q1 2023 Earnings of ($0.42) Per Share, SVB Leerink Forecasts (NASDAQ:IMTX) marketbeat.com - March 23 at 6:58 AM
	Immatics (NASDAQ:IMTX) Research Coverage Started at Bryan, Garnier & Co americanbankingnews.com - March 27 at 2:52 AM
	Immatics (NASDAQ:IMTX) Given New $25.00 Price Target at Chardan Capital americanbankingnews.com - March 26 at 4:24 AM
	Immatics (NASDAQ:IMTX) Forecasted to Earn Q1 2023 Earnings of ($0.42) Per Share americanbankingnews.com - March 25 at 1:52 AM
	Immatics Forecasted to Post FY2023 Earnings of ($1.71) Per Share (NASDAQ:IMTX) americanbankingnews.com - March 24 at 6:52 AM
	Immatics Announces Full Year 2022 Financial Results and Corporate Update finance.yahoo.com - March 21 at 7:54 AM
	Immatics (IMTX) Set to Announce Earnings on Tuesday americanbankingnews.com - March 20 at 9:00 AM
	Immatics (IMTX) Set to Announce Quarterly Earnings on Tuesday americanbankingnews.com - March 20 at 8:08 AM
	The past three years for Immatics (NASDAQ:IMTX) investors has not been profitable finance.yahoo.com - March 20 at 6:46 AM
	Immatics (NASDAQ:IMTX) Sees Significant Growth in Short Interest americanbankingnews.com - March 17 at 9:34 AM
	Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Immatics (IMTX) markets.businessinsider.com - February 6 at 10:00 AM
	Immatics N.V.'s (NASDAQ:IMTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? finance.yahoo.com - December 17 at 10:09 AM
	IMTX.O - Immatics NV \| Stock Price & Latest News \| Reuters reuters.com - December 16 at 10:49 PM
	Immatics Announces Third Quarter 2022 Financial Results and Business Update finance.yahoo.com - November 17 at 10:44 AM
	Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com - November 17 at 10:44 AM
	Does Immatics (IMTX) Have the Potential to Rally 77% as Wall Street Analysts Expect? finance.yahoo.com - October 31 at 12:30 PM
	Wall Street Analysts See an 81% Upside in Immatics (IMTX): Can the Stock Really Move This High? msn.com - October 14 at 3:07 PM
	Shareholders in Immatics (NASDAQ:IMTX) are in the red if they invested a year ago nz.finance.yahoo.com - October 10 at 3:41 PM
	Hot Stocks: Macau stocks drop on COVID worries; EDU, TAL plunge; AXNX downgrade; IMTX rises on clinical data seekingalpha.com - October 10 at 3:41 PM
	Immatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancers msn.com - October 10 at 10:41 AM
	Immatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAME finance.yahoo.com - October 10 at 10:41 AM
	Immatics Announces $110 Million Underwritten Offering of Ordinary Shares finance.yahoo.com - October 10 at 10:41 AM
	IMTX Immatics N.V. seekingalpha.com - September 27 at 8:15 PM
	Further weakness as Immatics (NASDAQ:IMTX) drops 11% this week, taking one-year losses to 26% nasdaq.com - September 13 at 7:06 PM
	IMTX.OQ - Immatics NV \| Stock Price & Latest News \| Reuters reuters.com - August 29 at 6:05 PM
	Immatics Announces First Cancer Patient Treated with Second-Generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME finanznachrichten.de - August 24 at 8:49 PM
	Immatics Announces First Cancer Patient Treated with Second-Generation ACTengine® TCR-T Candidate IMA203CD8 Targeting PRAME finance.yahoo.com - August 23 at 2:45 PM
	Wall Street Analysts Think Immatics (IMTX) Could Surge 82%: Read This Before Placing a Bet finance.yahoo.com - August 12 at 12:59 PM
	Immatics Announces Second Quarter 2022 Financial Results and Business Update nz.finance.yahoo.com - August 9 at 8:33 AM
	Strength Seen in Immatics (IMTX): Can Its 18% Jump Turn into More Strength? nasdaq.com - July 20 at 1:34 PM
	Do Its Financials Have Any Role To Play In Driving Immatics N.V.'s (NASDAQ:IMTX) Stock Up Recently? finance.yahoo.com - June 25 at 5:30 PM
	Immatics NV Ordinary Shares - Stock Chart morningstar.com - June 17 at 10:53 PM
	Editas in licensing deal with Immatics for cancer therapies seekingalpha.com - June 9 at 6:28 AM
	Immatics GAAP EPS of €1.35, revenue of €102.91M seekingalpha.com - June 2 at 10:19 AM
	Immatics Announces First Quarter 2022 Financial Results and Business Update finance.yahoo.com - June 2 at 10:19 AM
	Immatics (IMTX) Lags Q1 Earnings and Revenue Estimates finance.yahoo.com - June 2 at 10:19 AM
	Immatics stock rises on cell therapy program collaboration with Bristol Myers seekingalpha.com - June 2 at 10:19 AM
	What Kind Of Shareholders Own Immatics N.V. (NASDAQ:IMTX)? finance.yahoo.com - May 26 at 9:48 AM
	Immatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors morningstar.com - May 10 at 7:52 AM
	Immatics Initiates Phase 1 Clinical Trial of IMA401 in Advanced Solid Tumors markets.businessinsider.com - May 10 at 7:52 AM
	Immatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors finance.yahoo.com - May 10 at 7:52 AM
	Immatics (NASDAQ:IMTX) shareholders have endured a 37% loss from investing in the stock a year ago finance.yahoo.com - May 3 at 1:35 PM
	Wall Street Analysts See a 178% Upside in Immatics (IMTX): Can the Stock Really Move This High? finance.yahoo.com - April 15 at 2:21 PM
	Analysts Are Optimistic We'll See A Profit From Immatics N.V. (NASDAQ:IMTX) finance.yahoo.com - March 31 at 6:36 PM
	Immatics Announces Full Year 2021 Financial Results and Corporate Update finanznachrichten.de - March 25 at 12:05 AM
	Immatics Cash Position As Of Dec. 31 $164.3M benzinga.com - March 23 at 9:48 AM
	Here's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situation finance.yahoo.com - February 14 at 3:35 PM
	News Flash: Analysts Just Made A Captivating Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecasts nasdaq.com - December 16 at 6:10 AM
	News Flash: Analysts Just Made A Substantial Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecasts finance.yahoo.com - December 16 at 6:10 AM
	Immatics inks $920M licensing deal with Bristol Myers Squibb bizjournals.com - December 14 at 7:50 AM
	Bristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX marketwatch.com - December 14 at 7:50 AM

Get Immatics News Delivered to You Automatically

This page (NASDAQ:IMTX) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Immatics - IMTX News Today

IMTX Media Mentions By Week

IMTX Media Sentiment

IMTX News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info